Orchid Pharma Limited
Equibles does not estimate personal net worth.
Vridul Dhanuka has spoken on 1 earnings call across 1 company, most recently for Orchid Pharma Limited on August 21, 2026. Orchid Pharma Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“So, our ramp-up plan is to go to about 80% to 100% by the end of the first year. Initially, it would be slow and then increasing progressively. With respect to utilization, our long-term guidance on this is 80% in-house use and 20% selling to third-party.”
Orchid Pharma Limited
Transcript header (unverified)
Orchid Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended June 30, 2026
Orchid Pharma Limited
